Other publications - Jack Gleeson

Publications – Peer-reviewed

  • Gleeson JP, Nikolovski I, Dinatale R, Zucker M, Knezevic A, Patil S, Ged Y, Kotecha RR, Shapnik N, Murray S, Russo P, Coleman J, Lee CH, Stadler ZK, Hakimi AA, Feldman DR, Motzer RJ, Reznik E, Voss MH, Chen YB, Carlo MI. Comprehensive molecular characterization and response to therapy in FH-deficient renal cell carcinoma. Clinical Cancer Research. May 2021; 27; 10; 2910-2919. PMID: 33658299.
  • Gleeson JP, Keane F, Keegan NM, Mammadov E, Harrold E, Alhusaini A, Harte J, Eakin-Love A, O’Halloran P, MacNally S, Hennessy BT, Breathnach OS, Grogan W, Morris PG. Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma. Cancer Medicine. Jan 2020; 9: 469–475. PMID: 31756059.
  • L Prior, R O’Dwyer, AR Farooq, M Greally, C Ward, C O’Leary, R Aslam, W Darwish, N Ahmed, EC Othman, G Watson, D Kelly, J Gleeson, L Kiely, A Hassan, EM Walsh, D O’Reilly, A Jones, H Featherstone, M Lim, H Murray, BT Hennessy, LM Smyth, G Leonard, L Grogan, O Breathnach, P Calvert, AM Horgan, L Coate, EJ Jordan, D O’Mahony, R Gupta, MM Keane, J Westrup, K Duffy, M O’Connor, PG Morris, MJ Kennedy, S O’Reilly, J McCaffrey, CM Kelly, D Carney, G Gullo, J Crown, MJ Higgins, PM Walsh, JM Walshe. Pregnancy associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Res Treat. 2021 Aug;189(1):269-283. PMID: 34125341.
  • Gleeson JP, Motzer RJ, Lee CH. The current role for adjuvant and neoadjuvant therapy in renal cell cancer. Curr Opin Urol, Nov 2019; 29(6): 636–642. PMID: 31348025.
  • JP Gleeson, J Barry, S O’Reilly. Fatty Liver Disease and Diagnostic Imaging: The Ever-Increasing Challenges. New England Journal of Medicine. NEJM Letter to the Editor, Dec 2017; 377 (23): 2295-2297.
  • Gullo G, Gleeson JP. Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: does it matter? Translational Cancer Research 2018; 7 (6): 1357-1360.
  • JP Gleeson, NM Keegan, PG Morris. Neoadjuvant Pertuzumab, T-DM1, weekly paclitaxel and possible anthracyclines in HER2 positive early breast cancer treatment - Questions from the KRISTINE study. Translational Cancer Research. June 2018; Vol 7 (Suppl 5); S562-567.
  • JP Gleeson, NM Keegan, PG Morris. Adding Pertuzumab to Trastuzumab and Taxanes in HER2 positive Breast Cancer. Expert Opinion on Biological Therapy. 2018 Mar; 18 (3): 251-262. PMID: 29183167.
  • N Keegan, JP Gleeson, BT Hennessy, PG Morris. PI3K Inhibition to Overcome Endocrine Resistance in Breast Cancer: A Review. Expert Opinion on Investigational Drugs. 2018 Jan; 27(1): 1-15. PMID: 29252036.
  • J Gleeson, D Gallagher. Diagnosing Lynch Syndrome. Irish Medical Journal. 2016; Volume 109(10): 487. PMID: 28644592.
  • GA Watson, D Kelly, E Malone, J Gleeson, G McEntee, J Geoghegan, CM Kelly, R McDermott, J McCaffrey. Gastrointestinal Stromal Tumours: A 10-year Multicenter Audit. Cancer and Clinical Oncology. 2017; Vol 6 (1): 1-7.
  • G Watson, D Kelly, M Melland-Smith, J Gleeson, G McEntee, J McCaffrey. Get the GIST? Gastrointestinal Stromal Tumors. Irish Journal of Medical Science. 2016 May; 185(2): 319-26. PMID: 26833487.
  • J Gleeson, A Doyle, SF Oon, M Iqbal. First reported finding of a Malignant Pleural Mesothelioma in a patient post Liver Transplant. Irish Medical Journal. IMJ 2016 Apr; Volume 109(4): 400. PMID: 27685492.
  • JP Gleeson, HP Redmond, S O’Reilly. Siliconosis and the long-term implications of silent breast implant rupture. Breast J. 2019 Sep; 25 (5): 1002-1003. PMID: 31219206.
  • Chew S, Gleeson JP, McCarthy A, Watson GA, O’Dwyer R, Nicholson S, Capra M, Owens C, McDermott M, Daly P, Grant C. Leptomeningeal Relapse of Embryonal Rhabdomyosarcoma after 15 years. Irish Medical Journal. 2020 Dec; 112 (10): 1026-8. PMID: 32311247.
  • MacCann R, Gleeson JP, Aird JJ, Beausang, Breathnach O, Morris PG, Grogan W. An unusual presentation of a low-grade Follicular Lymphoma masquerading as a Meningioma. Ann Hematol Oncol. 2018; 5(6): 1211.
  • McNevin CS, Gleeson JP, Herlihy DB, Aird JJ, Robb WB, Kay EW, Morris PG, Grogan L, Breathnach OS. Bilateral Adrenalectomy for Metastatic Esophageal Adenocarcinoma: A Case Report. Journal of Oncology Practice. 2018 Jan; 14(1): 47-48. PMID: 28885880.
  • JP Gleeson, GB Woods, GA Watson, JW Ryan, JC O’Keane, JA McCaffrey. Synchronous Stage 1 Diffuse Large B-Cell Lymphomas of the Endometrium and Breast. Irish Journal of Medical Science. 2017 Nov; 186(4): 867-873. PMID: 28470353.
  • G Watson, J Gleeson, D Kelly, D Byrne, P De La Harpe-Golden, J Mulsow, A Fortune, D Carney. Non–Hodgkin’s Lymphoma of the Appendix. Cancer and Clinical Oncology. May 2016; Vol 5(1): 1-10.

Publications – Non-peer reviewed

  • CS McNevin, JP Gleeson, E Harrold, DB Herlihy, JJ Aird, C Gulman, PG Morris, L Grogan, OS Breathnach. Primary Effusion Lymphoma diagnosed by pericardiocentesis in HIV positive patient. Cancer Professional - Imagewise. Winter 2017.
  • J Gleeson, J McCaffrey. When all else fails: High dose chemotherapy with stem cell transplant rescue for metastatic testicular germ cell cancer – A Case Study. Irish Medical Independent. August 2016.
  • J Gleeson, E Jordan, R McDermott. A rare case of Brain Metastases in Prostate Cancer. Irish Medical Independent. January 2016.
  • M Lim, J Gleeson, D Kelly, G Watson, J McCaffrey. Medical Oncology: Prostate Cancer module. Hospital Doctor of Ireland. Published January 2016.

 Abstract publications

  • JP Gleeson, I Nikolovski, R Dinatele, A Knezevic, S Patil, Y Ged, RR Kotecha, N Shapnik, S Murray, P Russo, J Coleman, CH Lee, ZK Stadler, A Hakimi, DR Feldman, RJ Motzer, MH Voss, YB Chen, MI Carlo. Response to Systemic Therapy in metastatic Fumarate Hydratase (FH) deficient Renal Cell Carcinoma (RCC). ASCO Genitourinary Cancers Symposium 2020, San Francisco, USA. Kidney Cancer Journal. Dec 2020; 18 (4_Suppl): 16-17.
  • JP Gleeson, I Nikolovski, R Kotecha, Y Ged, N Shapnik, A Knezevic, DR Feldman, CH Lee, MH Voss, YB Chen, RJ Motzer, MI Carlo. Response to Systemic Therapy in metastatic Fumarate Hydratase (FH) deficient Renal Cell Carcinoma (RCC). ASCO Genitourinary Cancers Symposium 2020, San Francisco, USA. Journal of Clinical Oncology. 2020; 38 (6_Suppl): 686.
  • JP Gleeson, N Keegan, E Harrold, D Kamel, N Karadawi, E Mammadov, D Kelly, C O’Leary, P O’Halloran, K Egan, S Molloy, S MacNally, BT Hennessy, OS Breathnach, W Grogan, PG Morris. Reduced-Intensity Bevacizumab in Progressive Glioblastoma Multiforme (GBM) is Associated with Similar Overall Survival versus Standard-Dosing. ESMO Annual Meeting 2017, Madrid, Spain. Annals of Oncology, Volume 28, Issue suppl 5, 1 September 2017.
  • JP Gleeson, JP Greene, C Brady, C Goggin, W Mullally, C Dennehy, DG Power, BT Hennessy, OS Breathnach, RM Bambury, S O'Reilly, W Grogan, DC Collins, PG Morris, D O'Mahony. Cost saving analysis of reduced-dose versus standard-dose bevacizumab in recurrent glioblastoma. ASCO Annual Meeting 2018, Chicago. Abstract #
  • JP Gleeson, A Alhusaini, P O’Halloran, N Keegan, E Harrold, D Kamel, N Taj, E Mammadov, K Egan, S Molloy, S MacNally, B Hennessy, OS Breathnach, L Grogan, PG Morris. Identifying factors to predict benefit from bevacizumab in progressive glioblastoma multiforme (GBM). ASCO Annual Meeting 2017, Chicago. Abstract #
  • F Keane, E Walsh, J Sui, S Marks, C O’Leary, J Gleeson, M Keane, S O’Reilly. Long-term Trastuzumab treatment: can we ever stop? The Breast. 2017 Mar; Vol 32 (1): S66.
  • J Gleeson, H Ellis, L Prior, G Watson, K Nugent, M Lim, et al. Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A retrospective cohort study. ASCO Annual Meeting 2016, Chicago. Abstract #171314.
  • D Kelly, LM Prior, JP Gleeson, LM McSorley, R Kearns, C Brady, JS Yin Sui, MAI Dawod, L Burke, J McCarthy, R McDermott, J McCaffrey, DG Power, S O'Reilly, D O'Mahony, SP Finn, C O'Brien, RM Bambury. Response to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) patients with de novo epidermal growth factor receptor (EGFR) T790M and S768I resistance mutations. ASCO Annual Meeting 2017, Chicago. Abstract # e20557.
  • L Prior, MY Teo, M Greally, C Ward, C O’Leary, R Aslam, W Darwish, N Ahmed, E Walsh, G Watson, D Kelly, J Gleeson, A Hassan, L Kiely, H Featherstone, M Lim, H Murray, D Gallagher, J Westrup, B Hennessy, G Leonard, L Grogan, O Breathnach, P Morris, A Horgan, D O’Mahony, S O’Reilly, L Coate, R Gupta, M Keane, K Duffy, M O’Connor, J Kennedy, J McCaffrey, M Higgins, C Kelly, D Carney, G Gullo, J Crown, J Walshe. Pregnancy-associated Breast Cancer: Evaluating Maternal Outcomes. A multicentre study. San Antonio Breast Cancer Symposium (SABCS), San Antonio, October 2017.
  • N Keegan, J Gleeson, V Mallett, T Lyons, C McNevin, L Keating, S Picardo, I Ismail, M Milewski, K Egan, D Kehily, D Rance, D Easty, OS Breathnach, L Grogan, B Hennessy, PG Morris. A Prospective Study of Dose-Dense Doxorubicin Cyclophosphamide (AC) with the Biosimilar Lipegfilgrastim in Early Stage Breast Cancer (EBC). Abstract Submitted to ESMO 2017 Annual Meeting.
  • Lynam, L.A. Hanna, J. Gleeson, N. Doyle, P.G. Morris, L. Grogan, O.S. Breathnach. An investigation of Irish cancer patients and healthcare professionals’ (HCPs) use of, and views on complementary and alternative medicine (CAM). Abstract Submitted to ESMO 2017 Annual Meeting.
  • K Nugent, E Harrold, G Sugrue, R McDermott, L Prior, J Gleeson, et al. The accuracy of pre-operative MRI in predicting the rectal cancer tumour stage, node status and complete clinical response in patients who have undergone neoadjuvant chemoradiotherapy using histopathologic analysis as the reference standard. ASCO Annual Meeting 2016, Chicago. Abstract #170777.
  • L Prior, E Harrold, C O’Leary, K Nugent, J Gleeson, G Watson, et al. Toxicities in immunotherapy: Can they predict response? ASCO Annual Meeting 2016, Chicago. Abstract #171665.
  • M Lim, C O’Leary, E Harrold, G Watson, D Kelly, J Gleeson, et al. An audit on choice of antihypertensive use for tyrosine kinase inhibitor induced hypertension in patients with metastatic renal cell carcinoma in a tertiary referral centre. ASCO Annual Meeting 2016, Chicago. Abstract #170525.
  • G Watson, D Kelly, J Gleeson, L Prior, K Nugent, M Lim, et al. Testicular cancer: A single centre 25-year experience. ASCO Annual Meeting 2016, Chicago. Abstract #163903.
  • J Gleeson, D Kelly, G Watson, G Woods, T Walsh, C O’Keane, J Mc Caffrey. Primary Vaginal Melanoma in the setting of acquired mucosal melanosis - A Case Report and Literature Review. Abstract publication at the Melanoma Forum of Ireland annual scientific meeting 2015.
  • JP Gleeson, GB Woods, GA Watson, JW Ryan, JC O’Keane, JA McCaffrey. A case of synchronous Stage IE Diffuse Large B-Cell Lymphomas of the Endometrium and Breast. Abstract publication at the Haematology Association of Ireland conference 2015.
  • G Watson, J Gleeson, D Kelly, D Byrne, P De La Harpe-Golden, J Mulsow, A Fortune, D Carney. A Case or recurrent Non–Hodgkin’s Lymphoma of the Appendix. Abstract publication at the Haematology Association of Ireland conference 2015.
  • J Gleeson, A Lyons, L Gibson. An evaluation of the effects of Botulinum Toxin Type-A (BTX-A) Therapy, in children and young adults with Cerebral Palsy. Abstract publication at the Shaping the Future International Cerebral Palsy conference 2012.

Last updated: May 2022